Use

This test is intended to identify disease‑causing mutations in the HBB (beta‑globin) gene to assist in diagnosis, screening, and mutation confirmation for beta‑thalassemia in fetal specimens. It is offered by Quest Diagnostics Nichols Institute, San Juan Capistrano, and is specifically utilized in prenatal/fetal settings, where identifying pathogenic variants supports genetic counseling and family planning decisions.